| 舒张压n(%) |
|
|
| ≥90 mmhg | 7 (12.7%) | 6 (12.0%) |
| <90 mmhg | 48 (87.3%) | 44 (88.0%) |
| 左室射血分数n(%) |
|
|
| ≥50% | 38 (69.1%) | 35 (70.0%) |
| <50% | 17 (30.9%) | 15 (30.0%) |
| 左室心肌肥厚n(%) |
|
|
| 有 | 7 (12.7%) | 6 (12.0%) |
| 无 | 48 (87.3%) | 44 (88.0%) |
| 左室舒张功能障碍n(%) |
|
|
| 有 | 52 (94.5%) | 48 (96.0%) |
| 无 | 3 (5.5%) | 2 (4.0%) |
| 吸烟史n(%) |
|
|
| 有 | 12 (21.8%) | 12 (34.0%) |
| 无 | 43 (78.2%) | 38 (76.0%) |
| 饮酒史n(%) |
|
|
| 有 | 13 (23.6%) | 10 (20.0%) |
| 无 | 42 (76.4%) | 40 (80.0%) |
| NYHA分级n(%) |
|
|
| 2级 | 30 (54.5%) | 26 (52.0%) |
| 3级 | 22 (40.0%) | 20 (40.0%) |
| 4级 | 3 (5.5%) | 4 (8.0%) |
| 治疗n(%) |
|
|
| 强心药 | 12 (21.8%) | 11 (22.0%) |
| 利尿剂 | 26 (47.3%) | 24 (48.0%) |
| ACEI/ARB | 28 (21.8%) | 29 (58.0%) |
| β受体阻滞剂 | 29 (50.9%) | 29 (58.0%) |
| 他汀类 | 33 (60.0%) | 33 (66.0%) |
| 钙离子拮抗剂 | 9 (16.4%) | 17 (34.0%) |
| 降糖药 |
|
|
| 双胍类 | 11 (20.0%) | 13 (26.0%) |
| α葡萄糖苷酶抑制剂 | 27 (49.1%) | 17 (34.0%) |
| 磺脲类 | 4 (7.3%) | 3 (6.0%) |
| DPP4抑制剂 | 9 (16.4%) | 9 (18.0%) |
| 胰岛素 | 17 (27.3%) | 14 (28.0%) |
| 泌尿系统感染n(%) | 6 (10.9%) | 1 (2.0%) |
| 因心衰再入院n(%) | 18 (32.7%) | 23 (46.0%) |